Vanderbilt University Medical Center (VUMC)


 

Genomic Signatures in Adjuvant Therapy of HR+ EBC: Should We Consider Abemaciclib x2 Years to ET in Very-High Risk Patients? Can Longer CDK4/6i Duration Prevent Late Relapses?

212 views
February 28, 2021
0 Comments
Login to view comments. Click here to Login